Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Identification of clinically related requirements of a novel assistive device for people with a high spinal cord injury.

Gottlieb A, Plotnik M, Kizony R, Katsarou Z, Bostantjopoulou S, Zeilig G.

PLoS One. 2019 Jun 28;14(6):e0218393. doi: 10.1371/journal.pone.0218393. eCollection 2019.

2.

Two Novel KRIT1 and CCM2 Mutations in Patients Affected by Cerebral Cavernous Malformations: New Information on CCM2 Penetrance.

Scimone C, Donato L, Katsarou Z, Bostantjopoulou S, D'Angelo R, Sidoti A.

Front Neurol. 2018 Nov 14;9:953. doi: 10.3389/fneur.2018.00953. eCollection 2018.

3.

Functional rhythmic tongue movements.

Giza E, Dagklis IE, Kimiskidis V, Katsarou Z, Bostantjopoulou S.

Acta Neurol Belg. 2018 Jul 10. doi: 10.1007/s13760-018-0983-z. [Epub ahead of print] No abstract available.

PMID:
29987754
4.

Touchscreen typing-pattern analysis for detecting fine motor skills decline in early-stage Parkinson's disease.

Iakovakis D, Hadjidimitriou S, Charisis V, Bostantzopoulou S, Katsarou Z, Hadjileontiadis LJ.

Sci Rep. 2018 May 16;8(1):7663. doi: 10.1038/s41598-018-25999-0.

5.

The cortical excitability profile of patients with the G209A SNCA mutation versus patients with sporadic Parkinson's disease: A transcranial magnetic stimulation study.

Kimiskidis VK, Papayiannopoulos S, Sotirakoglou K, Karakasis H, Katsarou Z, Kazis DA, Papaliagkas V, Gatzonis S, Papadimitriou A, Hadjigeorgiou G, Bostanjopoulou S.

Neurophysiol Clin. 2018 Sep;48(4):203-206. doi: 10.1016/j.neucli.2018.04.002. Epub 2018 May 3.

PMID:
29729894
6.

A multimodal dataset for authoring and editing multimedia content: The MAMEM project.

Nikolopoulos S, Petrantonakis PC, Georgiadis K, Kalaganis F, Liaros G, Lazarou I, Adam K, Papazoglou-Chalikias A, Chatzilari E, Oikonomou VP, Kumar C, Menges R, Staab S, Müller D, Sengupta K, Bostantjopoulou S, Katsarou Z, Zeilig G, Plotnik M, Gotlieb A, Kizoni R, Fountoukidou S, Ham J, Athanasiou D, Mariakaki A, Comanducci D, Sabatini E, Nistico W, Plank M, Kompatsiaris I.

Data Brief. 2017 Nov 3;15:1048-1056. doi: 10.1016/j.dib.2017.10.072. eCollection 2017 Dec.

7.

Self-reported autonomic symptoms in Parkinson's disease: properties of the SCOPA-AUT scale.

Bostantjopoulou S, Katsarou Z, Danglis I, Karakasis H, Milioni D, Falup-Pecurariu C.

Hippokratia. 2016 Apr-Jun;20(2):115-120.

8.

D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population.

Kalinderi K, Bostantjopoulou S, Katsarou Z, Dimikiotou M, Fidani L.

Neurosci Lett. 2015 Oct 8;606:113-6. doi: 10.1016/j.neulet.2015.08.020. Epub 2015 Aug 20.

PMID:
26300542
9.

Detection of Novel Mutation in Ccm3 Causes Familial Cerebral Cavernous Malformations.

Scimone C, Bramanti P, Ruggeri A, Katsarou Z, Donato L, Sidoti A, D'Angelo R.

J Mol Neurosci. 2015 Nov;57(3):400-3. doi: 10.1007/s12031-015-0606-6. Epub 2015 Jun 27.

PMID:
26115622
10.

Lingual dystonia as a new clinical feature in corticobasal syndrome.

Giza E, Katsarou Z, Dagklis I, Bostantjopoulou S.

J Neurol Sci. 2015;353(1-2):187-8. doi: 10.1016/j.jns.2015.04.023. Epub 2015 Apr 24. No abstract available.

PMID:
25936255
11.

Clinical characteristics of Parkinson's disease patients in Greece: a multicenter, nation-wide, cross-sectional study.

Konitsiotis S, Bostantjopoulou S, Chondrogiorgi M, Katsarou Z, Tagaris G, Mavromatis I, Ntzani EE, Mentenopoulos G; members of the Greek Parkinson Study Group.

J Neurol Sci. 2014 Aug 15;343(1-2):36-40. doi: 10.1016/j.jns.2014.05.003. Epub 2014 May 11.

PMID:
24950902
12.

Evaluation of non-motor symptoms in Parkinson's Disease: An underestimated necessity.

Bostantjopoulou S, Katsarou Z, Karakasis C, Peitsidou E, Milioni D, Rossopoulos N.

Hippokratia. 2013 Jul;17(3):214-9.

13.

Cerebral amyloid angiopathy.

Tzimou M, Anastasiou A, Katsarou Z, Pyrpasopoulou A, Douma S.

Neuroradiol J. 2012 Nov;25(5):525-7. Epub 2012 Nov 9.

PMID:
24029086
14.

Association study of rs6812193 polymorphism with Parkinson's disease in a Greek population.

Kalinderi K, Bostantjopoulou S, Katsarou Z, Fidani L.

Neurosci Lett. 2013 Apr 29;541:190-2. doi: 10.1016/j.neulet.2013.02.048. Epub 2013 Mar 7.

PMID:
23473716
15.

Lack of association between CX3CR1 V249I and T280M polymorphisms and risk of Parkinson's disease in a Greek population.

Kalinderi K, Bostantjopoulou S, Katsarou Z, Clarimón J, Fidani L.

Genet Test Mol Biomarkers. 2012 Aug;16(8):974-7. doi: 10.1089/gtmb.2011.0330. Epub 2012 Jun 29.

PMID:
22747084
16.

Lack of association of the PICALM rs3851179 polymorphism with Parkinson's disease in the Greek population.

Kalinderi K, Bostantjopoulou S, Katsarou Z, Clarimón J, Fidani L.

Int J Neurosci. 2012 Oct;122(10):502-605. doi: 10.3109/00207454.2012.697083. Epub 2012 Jul 12.

PMID:
22715855
17.

TLR9 -1237 T/C and TLR2 -194 to -174 del polymorphisms and the risk of Parkinson's disease in the Greek population: a pilot study.

Kalinderi K, Bostantjopoulou S, Katsarou Z, Fidani L.

Neurol Sci. 2013 May;34(5):679-82. doi: 10.1007/s10072-012-1106-x. Epub 2012 May 3.

PMID:
22552867
18.

Sympathetic skin response in Parkinson's disease before and after mental stress.

Giza E, Katsarou Z, Georgiadis G, Bostantjopoulou S.

Neurophysiol Clin. 2012 Apr;42(3):125-31. doi: 10.1016/j.neucli.2011.11.002. Epub 2011 Nov 29.

PMID:
22500702
19.

Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease.

Kalinderi K, Fidani L, Katsarou Z, Bostantjopoulou S.

Int J Clin Pract. 2011 Dec;65(12):1289-94. doi: 10.1111/j.1742-1241.2011.02793.x. Review.

PMID:
22093536
20.

Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population.

Karakasis C, Kalinderi K, Katsarou Z, Fidani L, Bostantjopoulou S.

J Clin Neurosci. 2011 Dec;18(12):1744-5. doi: 10.1016/j.jocn.2011.03.015. Epub 2011 Oct 15.

PMID:
22001244
21.

Pupillometry and 123I-DaTSCAN imaging in Parkinson's disease: a comparison study.

Giza E, Fotiou D, Bostantjopoulou S, Katsarou Z, Gerasimou G, Gotzamani-Psarrakou A, Karlovasitou A.

Int J Neurosci. 2012 Jan;122(1):26-34. doi: 10.3109/00207454.2011.619285. Epub 2011 Oct 12.

PMID:
21883027
22.

Pupil light reflex in Parkinson's disease: evaluation with pupillometry.

Giza E, Fotiou D, Bostantjopoulou S, Katsarou Z, Karlovasitou A.

Int J Neurosci. 2011 Jan;121(1):37-43. doi: 10.3109/00207454.2010.526730. Epub 2010 Nov 1.

PMID:
21034369
23.

Performance of Greek demented and nondemented subjects on the Greek version of the Mattis Dementia Rating Scale. A validation study.

Katsarou Z, Bostantjopoulou S, Zikouli A, Kazazi E, Kafantari A, Tsipropoulou V, Kourtesi G, Peitsidou E.

Int J Neurosci. 2010 Nov;120(11):724-30. doi: 10.3109/00207454.2010.518779.

PMID:
20942587
24.

GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort.

Kalinderi K, Fidani L, Katsarou Z, Clarimón J, Bostantjopoulou S, Kotsis A.

Neurobiol Aging. 2011 Mar;32(3):546.e1-5. doi: 10.1016/j.neurobiolaging.2009.05.007. Epub 2009 Jul 1.

PMID:
19573950
25.

Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece.

Kalinderi K, Bostantjopoulou S, Paisan-Ruiz C, Katsarou Z, Hardy J, Fidani L.

Neurosci Lett. 2009 Mar 13;452(2):87-9. doi: 10.1016/j.neulet.2009.01.029. Epub 2009 Jan 15.

PMID:
19383421
26.

Reversible parkinsonism due to chronic bilateral subdural hematomas.

Bostantjopoulou S, Katsarou Z, Michael M, Petridis A.

J Clin Neurosci. 2009 Mar;16(3):458-60. doi: 10.1016/j.jocn.2008.03.016. Epub 2009 Jan 12.

PMID:
19138853
27.

(123)I-FP-CIT SPET striatal uptake in parkinsonian patients with the alpha-synuclein (G209A) mutation A.

Bostantjopoulou S, Katsarou Z, Gerasimou G, Costa DC, Gotzamani-Psarrakou A.

Hell J Nucl Med. 2008 Sep-Dec;11(3):157-9.

PMID:
19081858
28.

Personality profile of patients with juvenile myoclonic epilepsy.

Karachristianou S, Katsarou Z, Bostantjopoulou S, Economou A, Garyfallos G, Delinikopoulou E.

Epilepsy Behav. 2008 Nov;13(4):654-7. doi: 10.1016/j.yebeh.2008.08.006. Epub 2008 Sep 16.

PMID:
18755293
29.

No association of the Val158Met COMT polymorphism with Parkinson's disease in the Greek population.

Kalinderi K, Fidani L, Kourtesi G, Katsarou Z, Mioglou E, Bostantjopoulou S.

Eur J Neurol. 2008 Aug;15(8):e83. doi: 10.1111/j.1468-1331.2008.02186.x. No abstract available.

PMID:
18684304
30.

Quality of life and social-economic characteristics of greek male patients on long-term oxygen therapy.

Tsara V, Serasli E, Katsarou Z, Tsorova A, Christaki P.

Respir Care. 2008 Aug;53(8):1048-53.

31.

Sleep-disordered breathing and quality of life of railway drivers in Greece.

Nena E, Tsara V, Steiropoulos P, Constantinidis T, Katsarou Z, Christaki P, Bouros D.

Chest. 2008 Jul;134(1):79-86. doi: 10.1378/chest.07-2849. Epub 2008 Mar 17.

PMID:
18347205
32.

Health related quality of life in Greek patients with sleep apnea-hypopnea syndrome treated with continuous positive airway pressure.

Tsara V, Kaimakamis E, Serasli E, Katsarou Z, Christaki P.

Sleep Med. 2009 Feb;10(2):217-25. doi: 10.1016/j.sleep.2007.12.008. Epub 2008 Feb 15.

PMID:
18280789
33.

[Immune factors or depression? Fatigue correlates in Parkinson's disease].

Katsarou Z, Bostantjopoulou S, Hatzizisi O, Giza E, Soler-Cardona A, Kyriazis G.

Rev Neurol. 2007 Dec 16-31;45(12):725-8. Spanish.

34.

The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.

Kalinderi K, Fidani L, Bostantjopoulou S, Katsarou Z, Kotsis A.

Eur J Neurol. 2007 Oct;14(10):1088-90.

PMID:
17880562
35.

Aneurysm presenting as parkinsonism.

Bostantjopoulou S, Katsarou Z, Petridis A, Andreou A.

Neurology. 2006 Dec 12;67(11):2028. No abstract available.

PMID:
17159112
36.

Relapsing hemiparkinsonism due to recurrent meningioma.

Bostantjopoulou S, Katsarou Z, Petridis A.

Parkinsonism Relat Disord. 2007 Aug;13(6):372-4. Epub 2006 Oct 16.

PMID:
17049452
37.

Association of the Tau haplotype with Parkinson's disease in the Greek population.

Fidani L, Kalinderi K, Bostantjopoulou S, Clarimon J, Goulas A, Katsarou Z, Hardy J, Kotsis A.

Mov Disord. 2006 Jul;21(7):1036-9.

PMID:
16552760
38.

[Findings from molecular imaging with SPET camera and 123I-ioflupane in the differential diagnosis of Parkinsonism and essential tremor].

Gerasimou G, Tsolaki M, Bostanjopoulou S, Liaros G, Papanastasiou E, Balaris V, Katsarou Z, Fotiou F, Dedousi E, Baloyannis S, Milonas I.

Hell J Nucl Med. 2005 May-Aug;8(2):81-5. Greek, Modern.

PMID:
16142248
39.

Endothelial function markers in parkinsonian patients with hyperhomocysteinemia.

Bostantjopoulou S, Katsarou Z, Frangia T, Hatzizisi O, Papazisis K, Kyriazis G, Kiosseoglou G, Kazis A.

J Clin Neurosci. 2005 Aug;12(6):669-72.

PMID:
16040247
40.

Neuropsychological EEG activation in patients with juvenile myoclonic epilepsy.

Karachristianou S, Bostantjopoulou S, Katsarou Z, Kazis A.

Funct Neurol. 2004 Jul-Sep;19(3):185-9.

PMID:
15595713
41.

Auditory event-related potentials in Parkinson's disease in relation to cognitive ability.

Katsarou Z, Bostantjopoulou S, Kimiskidis V, Rossopoulos E, Kazis A.

Percept Mot Skills. 2004 Jun;98(3 Pt 2):1441-8.

PMID:
15291236
42.

Assessing quality of life in Parkinson's disease: can a short-form questionnaire be useful?

Katsarou Z, Bostantjopoulou S, Peto V, Kafantari A, Apostolidou E, Peitsidou E.

Mov Disord. 2004 Mar;19(3):308-12.

PMID:
15022185
43.

What can be worse than cerebral tuberculosis? A concomitant [correction of concommitant] Aspergillus infection.

Bostantjopoulou S, Katsarou Z, Tsitouridis I, Nicolaidis P, Kimiskidis V, Kazis A.

Arch Neurol. 2003 Aug;60(8):1163-4. No abstract available.

PMID:
12925377
44.

Evaluating dental status and prosthetic need in relation to medical findings in Greek patients suffering from idiopathic Parkinson's disease.

Anastassiadou V, Katsarou Z, Naka O, Bostanzopoulou M.

Eur J Prosthodont Restor Dent. 2002 Jun;10(2):63-8.

PMID:
12148146
45.

Amantadine sulfate infusion effect on N30 somatosensory evoked potentials in Parkinson's disease.

Bostantjopoulou S, Katsarou Z, Georgiadis G, Zafiriou D, Kazis A.

Clin Neuropharmacol. 2002 Mar-Apr;25(2):115-8.

PMID:
11981240
46.

Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation.

Bostantjopoulou S, Katsarou Z, Papadimitriou A, Veletza V, Hatzigeorgiou G, Lees A.

Mov Disord. 2001 Nov;16(6):1007-13.

PMID:
11748731
47.

Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39).

Katsarou Z, Bostantjopoulou S, Peto V, Alevriadou A, Kiosseoglou G.

Qual Life Res. 2001;10(2):159-63.

PMID:
11642686
48.

Concurrent validity of the Test of Nonverbal Intelligence in Parkinson's disease patients.

Bostantjopoulou S, Kiosseoglou G, Katsarou Z, Alevriadou A.

J Psychol. 2001 Mar;135(2):205-12.

PMID:
11403342
49.

Abnormality of N30 somatosensory evoked potentials in Parkinson's disease: a multidisciplinary approach.

Bostantjopoulou S, Katsarou Z, Zafiriou D, Gerasimou G, Alevriadou A, Georgiadis G, Kiosseoglou G, Kazis A.

Neurophysiol Clin. 2000 Dec;30(6):368-76.

PMID:
11191929
50.

Neuroacanthocytosis presenting as parkinsonism.

Bostantjopoulou S, Katsarou Z, Kazis A, Vadikolia C.

Mov Disord. 2000 Nov;15(6):1271-3. No abstract available.

PMID:
11104222

Supplemental Content

Loading ...
Support Center